Skip to content

A comparative study of clonidine and dexmedetomedine as an adjuvant to local anaesthetic drug in ultrasound guided regional anaesthesia

CLONIDINE VERSUS DEXMEDETOMEDINE AS AN ADJUVANT IN BRACHIAL PLEXUS BLOCK:A COMPARATIVE RANDOMIZED DOUBLE BLINDED PROSPECTIVE STUDY

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018486
Enrollment
60
Registered
2019-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified

Interventions

Intervention1: addition of adjuvant to local anaesthesia drug-clonidine or dexmedetomedine: both clonidine and dexmedetomedine has been compared as adjuvants to local anaesthetic drugs in brachial ple

Sponsors

Dr Asha H L
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA 1-2 physical status patients posted for upperlimb surgeries 2.patient willing to participate in study under regional anaesthesia

Exclusion criteria

Exclusion criteria: 1.patients of ASA physical status 3 and above 2.patients allergic to local anaesthesia drugs/study drugs 3.patients with coagaulation abnormalities/on antiplatelets/anticoagulants 4.patients not willing to takeup regional blocks for surgery 5.patients with contraindications for study drugs

Design outcomes

Primary

MeasureTime frame
1.To compare the total duration of analgesia and motor blockade between clonidine and dexmedetomedine Timepoint: morethan 6 hours of analgesia minimum

Secondary

MeasureTime frame
1.To study sedation score and patient satisfaction score perioperatively 2.Time duration for performance of usg guided blockTimepoint: 1.modified wilsons sedation score of 2 at 1 and 6 hours 2.5,10 minutes

Countries

India

Contacts

Public ContactDr Balasubramanyam P K

Columbia asia hospitals,mysore

drashahl88@gmail.com09986578970

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026